← Back to graph
Biomarker

C4 complement 24h urine

Selected indexed studies

  • Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus. (Arthritis Res Ther, 2025) [PMID:40533865]
  • Telitacicept use in children with IgA vasculitis nephritis: preliminary observations. (Pediatr Nephrol, 2025) [PMID:40042623]
  • The relevance of complement levels in assessing the activity of lupus nephritis of different pathological types. (Clin Rheumatol, 2025) [PMID:40192999]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Local graph